New England Private Wealth Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-18,880
| Closed | -$644K | – | 140 |
|
|
2019
Q3 | $644K | Buy |
18,880
+44
| +0.2% | +$1.5K | 0.16% | 82 |
|
|
2019
Q2 | $775K | Sell |
18,836
-2,172
| -10% | -$89.4K | 0.19% | 74 |
|
|
2019
Q1 | $845K | Buy |
21,008
+872
| +4% | +$35.1K | 0.22% | 62 |
|
|
2018
Q4 | $832K | Buy |
20,136
+2,857
| +17% | +$118K | 0.24% | 58 |
|
|
2018
Q3 | $724K | Sell |
17,279
-893
| -5% | -$37.4K | 0.19% | 72 |
|
|
2018
Q2 | $628K | Buy |
18,172
+26
| +0.1% | +$899 | 0.18% | 75 |
|
|
2018
Q1 | $612K | Buy |
18,146
+1,607
| +10% | +$54.2K | 0.17% | 79 |
|
|
2017
Q4 | $568K | Sell |
16,539
-583
| -3% | -$20K | 0.16% | 83 |
|
|
2017
Q3 | $578K | Sell |
17,122
-80
| -0.5% | -$2.7K | 0.17% | 77 |
|
|
2017
Q2 | $550K | Buy |
17,202
+2,685
| +18% | +$85.8K | 0.17% | 79 |
|
|
2017
Q1 | $472K | Sell |
14,517
-6,192
| -30% | -$201K | 0.15% | 81 |
|
|
2016
Q4 | $641K | Buy |
20,709
+722
| +4% | +$22.3K | 0.22% | 61 |
|
|
2016
Q3 | $642K | Buy |
19,987
+873
| +5% | +$28K | 0.23% | 63 |
|
|
2016
Q2 | $639K | Buy |
19,114
+81
| +0.4% | +$2.71K | 0.24% | 58 |
|
|
2016
Q1 | $535K | Buy |
19,033
+825
| +5% | +$23.2K | 0.22% | 63 |
|
|
2015
Q4 | $558K | Sell |
18,208
-1,565
| -8% | -$48K | 0.22% | 63 |
|
|
2015
Q3 | $590K | Buy |
19,773
+87
| +0.4% | +$2.6K | 0.25% | 54 |
|
|
2015
Q2 | $627K | Sell |
19,686
-1,223
| -6% | -$39K | 0.24% | 57 |
|
|
2015
Q1 | $687K | Buy |
20,909
+3,288
| +19% | +$108K | 0.27% | 53 |
|
|
2014
Q4 | $523K | Buy |
17,621
+2,175
| +14% | +$64.6K | 0.21% | 62 |
|
|
2014
Q3 | $433K | Buy |
15,446
+1,443
| +10% | +$40.5K | 0.17% | 67 |
|
|
2014
Q2 | $395K | Buy |
14,003
+71
| +0.5% | +$2K | 0.16% | 71 |
|
|
2014
Q1 | $425K | Buy |
13,932
+2,208
| +19% | +$67.4K | 0.18% | 64 |
|
|
2013
Q4 | $341K | Buy |
11,724
+1,583
| +16% | +$46K | 0.15% | 67 |
|
|
2013
Q3 | $278K | Buy |
10,141
+62
| +0.6% | +$1.7K | 0.15% | 61 |
|
|
2013
Q2 | $268K | Buy |
+10,079
| New | +$268K | 0.17% | 55 |
|